CIK 0000875045
- Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330112644
- Phone
- +1 617-679-2000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 670 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 1,371 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 245 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Human Resources gave up 634 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Chief Legal Officer gave up 807 shares (to pay taxes)
- 4 Shares withheld for taxes Head of Global Product Strat. gave up 445 shares (to pay taxes)
- 4 Shares withheld for taxes Head of Global Product Strat. gave up 1,165 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 1,502 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 3,201 shares (to pay taxes)
- 4 Shares withheld for taxes Head of Research gave up 443 shares (to pay taxes)
- 4 Shares withheld for taxes Head of Corporate Development gave up 563 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Accounting Officer gave up 476 shares (to pay taxes)
- 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 1,223 shares (to pay taxes)
- 4 Shares withheld for taxes Head of Development gave up 681 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Human Resources gave up 1,040 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Chief Legal Officer gave up 1,234 shares (to pay taxes)
- 4 Shares withheld for taxes Head of Development gave up 578 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Head of Development sold 110 shares at $157.21 ($17,293)
Page 4 of 86 · 1,714 filings